Bio-Techne Corp (NAS:TECH)
$ 83.805 0.965 (1.16%) Market Cap: 13.21 Bil Enterprise Value: 13.40 Bil PE Ratio: 66.51 PB Ratio: 6.55 GF Score: 92/100

Bio-Techne Corp at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 05:00PM GMT
Release Date Price: $73.15 (+1.61%)
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Awesome. Good morning, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team. Welcome to the Bio-Techne presentation. I have the management team up on stage with me. So this will be a 40-minute session, roughly 20, 25 minutes of presentation, followed by Q&A. If any of you in the room do have questions, feel free to either submit the questions via the portal or you can ping me directly.

And with that, I will pass it off to Kim for the presentation.

Kim Kelderman
Bio-Techne Corporation - COO

Thank you, Rachel. Thank you, JPMorgan, for hosting the company every year at this fantastic conference. Let me draw your attention to the safe harbor statement. You can find it on biotechne.com. And with that, let me start with introducing myself.

My name is Kim Kelderman, I'm going to be -- I am President and I'm going to be CEO of Bio-Techne on February 1. I want to thank the Board of Directors of Bio-Techne for the confidence they

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot